TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MedAdvisor Limited ( (AU:MDR) ) just unveiled an update.
MedAdvisor Limited has released its annual report for the fiscal year ending June 30, 2025. The report highlights the company’s continued efforts to strengthen its market position through technological advancements in medication management. The listing of its shares on the Australian Securities Exchange underscores its commitment to transparency and growth, potentially benefiting stakeholders by enhancing shareholder value and expanding its market reach.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare technology industry, providing digital solutions to enhance medication management. The company focuses on improving patient health outcomes through its innovative platforms, primarily targeting the pharmaceutical and healthcare sectors.
Average Trading Volume: 721,658
Technical Sentiment Signal: Sell
Current Market Cap: A$26.56M
For a thorough assessment of MDR stock, go to TipRanks’ Stock Analysis page.